BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18030360)

  • 1. 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth.
    Hennig R; Kehl T; Noor S; Ding XZ; Rao SM; Bergmann F; Fürstenberger G; Büchler MW; Friess H; Krieg P; Adrian TE
    Neoplasia; 2007 Nov; 9(11):917-26. PubMed ID: 18030360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions.
    Hennig R; Grippo P; Ding XZ; Rao SM; Buchler MW; Friess H; Talamonti MS; Bell RH; Adrian TE
    Cancer Res; 2005 Jul; 65(14):6011-6. PubMed ID: 16024599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
    Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE
    Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer.
    Ding XZ; Tong WG; Adrian TE
    Pancreatology; 2001; 1(4):291-9. PubMed ID: 12120207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway.
    Tong WG; Ding XZ; Witt RC; Adrian TE
    Mol Cancer Ther; 2002 Sep; 1(11):929-35. PubMed ID: 12481414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primers on molecular pathways - lipoxygenases: their role as an oncogenic pathway in pancreatic cancer.
    Comba A; Pasqualini ME
    Pancreatology; 2009; 9(6):724-8. PubMed ID: 20016244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.
    Xu XC; Shappell SB; Liang Z; Song S; Menter D; Subbarayan V; Iyengar S; Tang DG; Lippman SM
    Neoplasia; 2003; 5(2):121-7. PubMed ID: 12659684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation.
    Hennig R; Osman T; Esposito I; Giese N; Rao SM; Ding XZ; Tong WG; Büchler MW; Yokomizo T; Friess H; Adrian TE
    Br J Cancer; 2008 Oct; 99(7):1064-73. PubMed ID: 18781173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue.
    Hennig R; Ding XZ; Tong WG; Schneider MB; Standop J; Friess H; Büchler MW; Pour PM; Adrian TE
    Am J Pathol; 2002 Aug; 161(2):421-8. PubMed ID: 12163367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
    Al-Aynati MM; Radulovich N; Ho J; Tsao MS
    Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
    Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis.
    Rosty C; Geradts J; Sato N; Wilentz RE; Roberts H; Sohn T; Cameron JL; Yeo CJ; Hruban RH; Goggins M
    Am J Surg Pathol; 2003 Dec; 27(12):1495-501. PubMed ID: 14657708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12/15 Lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12-HETE and 13-HODE in animal models.
    Chang J; Jiang L; Wang Y; Yao B; Yang S; Zhang B; Zhang MZ
    Oncotarget; 2015 Feb; 6(5):2879-88. PubMed ID: 25576922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor.
    Funahashi H; Satake M; Dawson D; Huynh NA; Reber HA; Hines OJ; Eibl G
    Cancer Res; 2007 Aug; 67(15):7068-71. PubMed ID: 17652141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion.
    Moussalli MJ; Wu Y; Zuo X; Yang XL; Wistuba II; Raso MG; Morris JS; Bowser JL; Minna JD; Lotan R; Shureiqi I
    Cancer Prev Res (Phila); 2011 Dec; 4(12):1961-72. PubMed ID: 21881028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.